Cerebral Vasospasm Market Global Market 2018-2023: Key Players Headsense Medical Ltd, B. Braun Melsungen AG, Minnetronix, Inc, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH and H. Lundbeck A/S, Actelion Pharmaceuticals Ltd, GE Healthcare, Edge T

Market Scenario

The global cerebral vasospasm market is expected to register an approximate CAGR of 5.4% during the forecast period. The narrowing of cerebral arteries is termed as cerebral vasospasm. Cerebral vasospasm is most commonly observed in patients who survive subarachnoid hemorrhage. Narrowing of cerebral artery leads to cerebral ischemia and then death. Increasing prevalence of subarachnoid hemorrhage and a rise in the prevalence of traumatic brain injury is the key factor driving the growth of the market. According to the Centers for Disease Control and Prevention 2017, 30% of the total injury deaths are due to traumatic brain injury in the US. Other factors contributing to the growth of the market are increasing hypertension among the population, rising adoption of smoking, changing lifestyle, growing geriatric population, increasing prevalence of bleeding disorders, rising use of blood thinners and the introduction of technologically advanced treatments.

However, factors such as high cost associated with treatment, risks associated with drugs and medication and a shortage of skilled professionals are expected to hinder the market growth during the forecast period.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/1418

Segmentation

The global cerebral vasospasm market is segmented on the basis of diagnosis, treatment, and end-user. The global cerebral vasospasm market, by diagnosis, is segmented into CT scan, computed tomography angiography (CTA), digital subtraction angiography (DSA), magnetic resonance angiography (MRA), transcranial Doppler (TCD), and others. The treatment segment is segmented into nimodipine, triple-h therapy, balloon angioplasty, vasopressors, inotropes, thrombolytic agents and anti-inflammatory agents. On the basis of end-users, the global cerebral vasospasm market is segmented into hospitals and clinics, ambulatory surgical centers, trauma centers, emergency departments and others.

On the basis of region, the global cerebral vasospasm market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and South America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

Key players

Some of the key players in this market are Headsense Medical Ltd (Israel), B. Braun Melsungen AG (Germany), Minnetronix, Inc (US), Bristol-Myers Squibb Company (US), Boehringer Ingelheim GmbH (Germany) and H. Lundbeck A/S (Denmark), Actelion Pharmaceuticals Ltd, GE Healthcare, Edge Therapeutics, Inc, SIEMENS AG, Koninklijke Philips N.V, and others.

Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/1418

Regional Market Summary

The cerebral vasospasm market is dominated by North America owing to the increasing number of traumatic brain injuries in this region. According to the Centers for Disease Control and Prevention, the Traumatic Brain Injury-related Emergency Department visits increased by 47% from 2007 to 2013. Such high incidences of brain traumatic injuries influence market growth. Furthermore, increased adoption of technologically advanced medical implants and the growing healthcare expenditure contribute to enhance the market growth in this region.

It is estimated that Europe was the second largest in the global cerebral vasospasm market. Rising health burden due to smoking drives the market in this region. According to the NHS Digital report on Statistics on Smoking, England, 2018, 484,700 people were hospitalized due to health issues relating to smoking in 2017. This provides favorable backgrounds for the market to grow in this region.

The cerebral vasospasm market in Asia-Pacific is likely to witness growth owing to the increasing number of elderly people. Brain aneurysms develop after the age of 40 years and are commonly observed in the elderly population. According to the Asian Development Bank (ADB), Asia’s geriatric population is expected to reach 923 million by 2050. This contributes to the positive market growth in this region.

The Middle East and Africa holds the least share in the global cerebral vasospasm market due to the presence of stringent government policies and poor economies. However, growing government initiatives, increasing private players investments, and well-equipped healthcare facilities are likely to enhance the market growth in this region.

Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/1418

About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com

This release was published on openPR.